Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,709Revenue $M0.0Net Margin (%)0Z-Score-8.6
Enterprise Value $M1,810EPS $-0.5Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %-20.0Quick Ratio0.5Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-26.3Current Ratio0.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-66.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M409ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with MNKD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
MNKDJean-Marie Eveillard 2013-03-31 Sold Out -0.01%$2.31 - $3.56
$ 4.1834%Sold Out0
MNKDJean-Marie Eveillard 2012-12-31 Buy 0.01%$1.85 - $2.83
$ 4.1848%New holding800,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MNKD is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

MNKD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Edstrom HakanPresident & CEO 2015-03-27Sell73,460$5.21-4.8 view
Martens JuergenCorporate VP and COO 2015-03-02Sell121,333$6.54-24.16 view
Thomson DavidVP & General Counsel 2015-02-19Sell68,662$7.19-31.02 view
Edstrom HakanPresident & CEO 2015-02-10Sell73,460$7.75-36 view
Palumbo DianeVice President, Human Resource 2015-02-05Sell149,833$6.95-28.63 view
Thomson DavidVP & General Counsel 2015-02-05Sell80,000$7-29.14 view
Edstrom HakanPresident & CEO 2015-01-30Sell73,460$6.34-21.77 view
Palumbo DianeVice President, Human Resource 2015-01-05Sell188,999$5.95-16.64 view
Edstrom HakanPresident & COO 2014-12-01Sell74,668$5.89-15.79 view
Palumbo DianeVice President, Human Resource 2014-12-01Sell183,522$5.89-15.79 view

Press Releases about MNKD :

    Quarterly/Annual Reports about MNKD:

    News about MNKD:

    Articles On GuruFocus.com
    own Mar 02 2015 
    investment Feb 28 2015 
    Analysts Weigh in on MannKind Following Q4 Results Feb 27 2015 
    Portfolio 1 Jan 03 2015 
    What to Watch for: November 3-7 Nov 04 2014 
    Roche to Acquire InterMune and Deliver Hope to Patients Worldwide Aug 25 2014 
    How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug Aug 20 2014 
    Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
    Evaluating MannKind (MNKD) & Sanofi (SNY) Agreement for Afrezza Aug 15 2014 
    There is a Tide in the Affairs of MannKind: When Taken At the Flood, Will Lead to Fortune Aug 14 2014 

    More From Other Websites
    8 Analyst Stocks Under $10 With Massive Upside Calls Apr 18 2015
    What's Afrezza's Ultimate Potential For MannKind? Apr 16 2015
    Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, Coach, Etsy, Intel, MannKind, Netflix,... Apr 16 2015
    Short Sellers Increase Their Bets Against Biotech Stocks Apr 13 2015
    The Most Shorted Nasdaq Stocks List Once Again Topped by Sirius Apr 13 2015
    Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind Apr 10 2015
    Lightning Round: I'm not a believer in this Apr 07 2015
    One Big Step Coming For MannKind? Apr 01 2015
    MannKind: More Confidence, Lower Target Mar 24 2015
    Goldman Downgrade Makes MannKind A Buy Mar 20 2015
    Is This Why MannKind Investors Are Bullish? Mar 18 2015
    Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press... Mar 18 2015
    MannKind's Financial Health Complicated by Looming $100M Debt Payment Mar 18 2015
    Why Does Wall Street Hate MannKind? Mar 09 2015
    MANNKIND CORP Financials Mar 07 2015
    10-K for MannKind Corp. Mar 04 2015
    US STOCKS-Wall St falls from records, led by technology stocks Mar 03 2015
    US STOCKS-Wall St falls from records, led by technology stocks Mar 03 2015
    MannKind's Charts Suggest Waiting on the Stock After Goldman's Downgrade Mar 03 2015
    Goldman Downgrades MannKind To Sell, Should You Follow Their Lead? Mar 03 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)